Abstract:Background: Phosphatase of regenerating liver (PRL-3) promotes cell invasiveness, but its role in genomic integrity remains unknown. We have reported that PRL-3 recruits to telomeric DNA by RAP1/TRF2 protein. Overexpression of PRL-3 in colon cancer cells and primary fibroblasts promotes structural abnormalities of telomere, telomere deprotection, DNA damage response, chromosomal instability. Aim: To substantiate the previous results and further assess the physiologic relevance of PRL-3 in tumorigenesis, also to explore the prediction role PRL-3 in clinical patients. We detected the expression of PRL-3, telomere length, H3K9me and p-H2AX in the colon cancer and thyroid cancer samples. Methods: We collected 273 colorectal cancer patients and stained with PRL-3 antibody and counterstained with HE. Semiquantitative scoring was performed. Microscopic analysis was done by 2 of the authors. Tissues-chips were obtained from Alenabio (Th802a, thyroid). Results: We retrospectively analyzed a cohort of colorectal cancer tissues (n = 269) stained with anti-PRL-3 (clone 3B6). Although the majority of mitotic cells were bipolar, more multipolar mitoses, an indicator of chromosomal missegregation and chromosomal instability, was observed in PRL-3 positive tissues than in negative tissues (Fig 1A). Also in the PRL-3 positive tissues, more anaphase bridges were detected ( Fig 1A ). These results suggest that PRL-3 levels positively correlate with chromosomal instability in colon cancer tissues. Next, we analyzed 12 freshly dissected colon cancer tissues, with WI38 control and PRL-3-overexpressing cells as reference samples. We detected varying levels of PRL-3 proteins in these tissues, and the level of stably overexpressed PRL-3 in WI38 cells was comparable to some of these tissues. An inverse correlation between PRL-3 and telomere length was revealed, while PRL-3 showed positive correlations with gamma-H2AX and H3K9me3 ( Fig 1B ). We also performed quantitative FISH (qFISH) analysis of telomere length and immunohistochemical staining of PRL-3 with thyroid tissue chips containing 80 samples. We found decreased telomere staining in adenocarcinoma tissues (n = 40) with positive PRL-3 expression, particularly in those of stage I (n = 23) ( Fig 1C ). No correlation was observed in thyroid adenoma (n = 40) or stage II/III/IV adenocarcinoma (n = 17) ( Fig 1C ). With the same thyroid tissue-chip, we evaluated association between PRL-3 and senescence. In stage I thyroid adenocarcinoma tissues, positive staining of PRL-3 correlated with positive H3K9me3 staining, but such correlation was not observed in thyroid adenoma or Stage II/III/IV adenocarcinoma ( Fig 1D ). Conclusion: These results raise the possibility that PRL-3-promoted telomere deprotection and senescence are early events during the development and progression of cancer. Our results uncover a novel role of PRL-3 in tumor development through its adverse impact on telomere homeostasis.[Figure: see text]

Oncogenic Roles of Prl-3 in Flt3-Itd Induced Acute Myeloid Leukaemia

PRL2 Phosphatase Enhances Oncogenic FLT3 Signaling Via Dephosphorylation of the E3 Ubiquitin Ligase CBL at Tyrosine 371

Expression and Clinical Significance of Phospholipase D1 in De Novo Acute Myeloid Leukemia

FLT3-ITD As a Prognostic Factor for Chinese Patients with Acute Myeloid Leukemia

Metastasis-associated PRL-3 Induces EGFR Activation and Addiction in Cancer Cells

Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling

PRL-3 Activates Mtorc1 in Cancer Progression

PRL-3 promotes ubiquitination and degradation of AURKA and colorectal cancer progression via dephosphorylation of FZR1.

PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

SH3BGRL As a Novel Prognostic Biomarker is Down-Regulated in Acute Myeloid Leukemia

PRL-3 Facilitates Hepatocellular Carcinoma Progression by Co-Amplifying with and Activating FAK

Phosphatase Regenerating Liver 3 Participates in Integrinβ1/FAK-Src/MAPK Signaling Pathway and Contributes to the Regulation of Malignant Behaviors in Hepatocellular Carcinoma Cells

Prognostic Value of PRL-3 Overexpression in Early Stages of Colonic Cancer.

The Expression of PRL-3 Correlates with Chromosomal Instability in Colon Cancer and Thyroid Cancer

PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer.

Prl-3 Promotes Epithelial Mesenchymal Transition By Regulating Cadherin Directly

FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia

Prl-3 Promotes Telomere Deprotection and Chromosomal Instability

PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse

LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia

High Expression of PRL-3 Can Promote Growth of Gastric Cancer and Exhibits a Poor Prognostic Impact on Patients